What is GeneDx Holdings's EV / EBITDA?

GeneDx Holdings (WGS) reported EV / EBITDA of 310.1× in Q4 2025.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

GeneDx Holdings WGS EV / EBITDA

EV / EBITDA at other companies

Quest DiagnosticsDGX

12.6×-0.6×

RevvityRVTY

16.7×-2.2×

Labcorp HoldingsLH

13.3×-1.4×

IlluminaILMN

17.7×—

Agilent TechnologiesA

18.8×-0.5×

DanaherDHR

20.5×-2.1×

Other financials

Income statement

See full

Revenue$102.3M+17.4%

Gross profit$68.2M+16.6%

Operating income-$57.5M-1,163%

Net income-$63.3M-870%

EPS (diluted)-$2.16-839%

Balance sheet

See full

Cash & equivalents$94.9M-5.7%

Total debt$96.7M+82.5%

Total equity$254.1M-1.3%

Total assets$506.3M+13.4%

Cash flow

See full

Operating cash flow-$32.4M-418%

CapEx$6.5M+5.3%

Free cash flow-$38.9M-1,059%

Valuation

See full

Market cap$1.89B-24.3%

Profitability

See full

Gross margin69.6%+4.3pp

Operating margin-14.9%—

Net margin-17.6%—

FCF margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-30.4%—

Debt / equity0.4×+0.2×

Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

enterprise value/ebitda=310.1×

Based on the most recent quarter.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GeneDx Holdings's EV / EBITDA?: GeneDx Holdings (WGS) reported EV / EBITDA of 310.1× in Q4 2025.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.